Attraction of the leading scientists to Russian institutions of higher learning, research organizations of the governmental academies of sciences, and governmental research centers of the Russian Federation

i-SCALARE Supercomputer Systems Laboratory

About the laboratry

In 2010, the National Nuclear Research University "MEPhI" was one of the winners of the open grant competition that was held in compliance with Resolution of the Government of the Russian Federation No.220 of April 9, 2010, "On measures designed to attract the world's leading scientists to Russian institutions of higher learning, research institutions of the governmental academies of sciences and governmental research centers of the Russian Federation". As a result, on December 1, 2010, the university inaugurated a new structural subdivision, the "Intel Supercomputer Applications Laboratory for Advanced Research in Biomedicine, Pharmacology, and Nanostructures", a.k.a. "i-SCALARE".

Link to official website

Grant Agreement No.: 11.G34.31.0016

Host institution of higher learning:
State educational institution of higher professional education "National Nuclear Research University "MEPhI"

Scientific research area:
Information technologies and computer systems

Project goal:
To design new supercomputer technologies for biomedicine, pharmacology, and nanostructured systems for the purpose of developing new and advanced medications.

Key project objectives:
1. To formulate the architecture and software requirements for the future computer system to ensure optimal modeling of processes in biomedicine and pharmaceutics;
2. To develop the architecture of a super-powerful computer system and the structure of scalable problem-targeted software products;
3. To build and configure a hardware and software model of the supercomputer system;
4. To develop and configure software applications required to model the most relevant processes in biomedicine and pharmaceutics.

Anticipated project outputs:
To develop software applications and optimise the architecture of the supercomputer to address the problems of innovative development of biomedicine, pharmacology, and nanotechnologies based on highly productive computations.


Back to top